Low-dose aspirin use and the risk of synchronous metastatic colorectal cancer: results from a population-based study
Background Long-term aspirin use has been associated with a reduced risk of colorectal cancer (CRC), but its impact on metastatic disease at diagnosis is less studied. This study investigated the associations between low-dose aspirin use and the presence of distant metastases at CRC diagnosis. Methods Using the Colorectal Cancer Database Sweden (CRCBaSe), exposure to low-dose aspirin was defined as ≥12 months of use and categorized as non-users, past users, or current users. Adjusted logistic regression estimated odds ratios (ORs) with 95% confidence intervals (CIs). Results Among 81,269 CRC patients, 18,943 (23%) had synchronous distant metastases; 15,424 (19%) were current and 5,044 (6%) past aspirin users. Current users had lower odds of synchronous metastases, (OR adj 0.86, 95% CI 0.82-0.90), most pronounced in right-sided colon cancer (OR adj 0.79, 95% CI 0.74-0.86). In duration-dependent analyses, the reduction persisted in right-sided colon cancer regardless of use duration, and among rectal cancer patients with specific use patterns, but not in left-sided colon cancer. Past users had reduced odds of synchronous metastases only in right-sided colon cancer (OR adj 0.84, 95% CI 0.77-0.92), independent of use duration. Conclusions Low-dose aspirin use was associated with lower odds of distant metastases at CRC diagnosis, particularly in right-sided colon cancer.
Authors
- Mehrnoosh Shahrivar (ORCID: https://orcid.org/0000-0003-1994-0361)
- Bengt L. G. Glimelius (ORCID: https://orcid.org/0000-0002-5440-791X)
- Caroline A.M. Nordenvall (ORCID: https://orcid.org/0000-0002-5112-8894)
- Caroline E. Dietrich (ORCID: https://orcid.org/0000-0001-8231-8183)
- Anna Martling (ORCID: https://orcid.org/0000-0001-5998-4735)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41416-026-03663-z
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00